 | | PRD_001255 | | Name: | Promothiocin A | | Formula: | C36 H47 N11 O8 S2 | | Definition date: | 2014-12-10 | | Last modified: | 2023-11-03 |
|
 | | PRD_000553 | | Name: | APSTATIN | | Formula: | C23 H33 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000554 | | Name: | Cyclotheonamide A | | Formula: | C36 H46 N9 O8 | | Definition date: | 2012-02-03 | | Last modified: | 2023-11-03 |
|
 | | PRD_000555 | | Name: | AERUGINOSIN 298-A | | Formula: | C30 H48 N6 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000561 | | Name: | FR901277 | | Formula: | C47 H63 N9 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002098 | | Formula: | C29 H43 N10 O9 | | Definition date: | 2013-08-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_002103 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C30 H51 N5 O8 S | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002107 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H47 N5 O8 S2 | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002111 | | Name: | 3,5-difluoro-Nalpha-[(2E,5S)-5-methylhept-2-enoyl]-N-[(2S,6aS,12S,13R,15aS,21S,23aS)-2,13,21-trimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-L-phenylalaninamide | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2023-11-03 |
|
 | | PRD_002126 | | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | | Formula: | C38 H54 N7 O10 P | | Definition date: | 2014-12-03 | | Last modified: | 2023-11-03 |
|
 | | PRD_002132 | | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | | Formula: | C37 H47 N9 O7 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_002139 | | Formula: | C51 H80 N7 O16 P S2 | | Definition date: | 2015-02-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002156 | | Name: | N-acetyl-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C24 H45 N5 O6 | | Definition date: | 2016-03-16 | | Last modified: | 2023-11-03 |
|
 | | PRD_002173 | | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | | Formula: | C39 H67 N5 O7 | | Definition date: | 2016-07-27 | | Last modified: | 2023-11-03 |
|
 | | PRD_002183 | | Name: | (2S,5S,8S,14R,17E)-2-(cyclohexylmethyl)-5-(4-fluorobenzyl)-8-(4-nitrobenzyl)-3,6,9,16,19-pentaoxo-1,4,7,10,15-pentaazacyclononadec-17-ene-14-carboxylic acid | | Formula: | C36 H43 F N6 O9 | | Definition date: | 2016-09-21 | | Last modified: | 2023-11-03 |
|
 | | PRD_002204 | | Formula: | C21 H34 N4 O7 | | Definition date: | 2016-07-27 | | Last modified: | 2023-11-03 |
|
 | | PRD_002214 | | Formula: | C35 H48 N6 O8 | | Definition date: | 2015-12-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_002239 | | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C32 H57 N7 O7 S | | Definition date: | 2017-08-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_002250 | | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | | Formula: | C32 H40 N4 O5 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002252 | | Name: | N,N-diethyl-N~2~-[(2E)-3-phenylprop-2-enoyl]-L-asparaginyl-4-fluoro-N-[(naphthalen-1-yl)methyl]-L-phenylalaninamide | | Formula: | C37 H39 F N4 O4 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002253 | | Name: | (2S)-N-{(2S)-3-methoxy-1-[(naphthalen-1-ylmethyl)amino]-1-oxopropan-2-yl}-4-oxo-2-[(3-phenylpropanoyl)amino]-4-(1H-pyrrol-1-yl)butanamide (non-preferred name) | | Formula: | C32 H34 N4 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002254 | | Name: | (2~{S})-~{N}-[(2~{S})-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxidanylidene-propan-2-yl]-4-oxidanylidene-2-(3-phenylpropanoylamino)-4-piperidin-1-yl-butanamide | | Formula: | C33 H40 N4 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002255 | | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | | Formula: | C31 H38 N4 O4 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002256 | | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | | Formula: | C28 H35 N5 O7 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002257 | | Name: | Globomycin | | Formula: | C32 H57 N5 O9 | | Definition date: | 2019-08-28 | | Last modified: | 2023-11-03 |
|
